SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 68 filers reported holding SYNTA PHARMACEUTICALS CORP in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $3,000 | -40.0% | 11,124 | -15.9% | 0.00% | – |
| Q4 2015 | $5,000 | -97.4% | 13,228 | -88.3% | 0.00% | -100.0% |
| Q3 2015 | $196,000 | -26.0% | 112,741 | -5.2% | 0.00% | -25.0% |
| Q2 2015 | $265,000 | +35.9% | 118,870 | +18.5% | 0.00% | +100.0% |
| Q1 2015 | $195,000 | -14.5% | 100,272 | +16.5% | 0.00% | -33.3% |
| Q4 2014 | $228,000 | -4.6% | 86,049 | +8.2% | 0.00% | 0.0% |
| Q3 2014 | $239,000 | -31.1% | 79,550 | -6.3% | 0.00% | -25.0% |
| Q2 2014 | $347,000 | -30.5% | 84,883 | -26.7% | 0.00% | -33.3% |
| Q1 2014 | $499,000 | +136.5% | 115,835 | +188.3% | 0.01% | +100.0% |
| Q4 2013 | $211,000 | -33.0% | 40,172 | -19.5% | 0.00% | -57.1% |
| Q3 2013 | $315,000 | +61.5% | 49,874 | +27.7% | 0.01% | +75.0% |
| Q2 2013 | $195,000 | – | 39,052 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 21,704,847 | $5,209,000 | 7.19% |
| CAXTON CORP | 67,000 | $16,000 | 0.02% |
| McQueen, Ball & Associates Inc. | 102,742 | $25,000 | 0.02% |
| TWO SIGMA SECURITIES, LLC | 36,056 | $9,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,398,330 | $336,000 | 0.01% |
| WEDBUSH SECURITIES INC | 45,000 | $11,000 | 0.00% |
| Roundview Capital LLC | 21,100 | $5,000 | 0.00% |
| Renaissance Technologies | 2,332,995 | $560,000 | 0.00% |
| PANAGORA ASSET MANAGEMENT INC | 618,599 | $148,000 | 0.00% |
| Virtu KCG Holdings LLC | 107,071 | $26,000 | 0.00% |